Backus L, Belperio PS, Shahoumian TA, Mole LA. Impact of sustained virologic response with direct-acting antiviral treatment on mortality and hepatocellular carcinoma. AASLD 2017, abstract 78.
Europese Commissie keurt risankizumab (Skyrizi) goed voor behandeling matig tot ernstig actieve colitis ulcerosa
okt 2024 | IBD